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Abstract
The influence of the methylphosphoester group on the reversible reaction shown below was studied.
Evaluation of the rate constants for the system depicted as well as for the analogous equilibrium involving
the nucleoside deoxyguanosine showed that whereas the chloride anation is slowed down by the presence of
the methylphosphoester group, the hydrolysis rate constant is not significantly altered. This result speaks
against a catalytic role of the 5’-phosphodiester group in the hydrolysis of cisplatin monoadducts with DNA,
as suggested previously (Kozelka & Barre, Chem. Eur. J. 1997, 3, 1405-1409).
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The reaction of Me-5’-dGMP- and dGuo with the diaqua form of cisplatin, cis-[Pt(NH3)2(H20)2]2+, in 0.1 M
NaC104 was also investigated and the corresponding rate constants determined. The phosphodiester group
accelerates the replacement of the first H20 ligand 10 times, and that of the second H20 ligand ~2 times.
1. Introduction
A number of experimental observations have indicated that the antitumor activity of cisplatin (cis-
[PtC12(NH3)2]) is related to DNA damage caused by covalent platinum binding to nucleobases [1,2]. The
cytotoxic effect is generally ascribed to the major cisplatin-DNA adducts, the 1.,2-GG and 1,2-AG intrastrand
diadducts, which represent -85% of all adducts formed upon cisplatin-DNA interaction in vivo as well as
after DNA platination under certain in vitro conditions [3]. The assumption that the 1,2-intrastrand
crosslinks are at the origin of antitumor activity is based, on one hand, on the finding that in E. Coli, these
adducts are indeed cytotoxic [4,5], and on the other hand, on the correlation between the levels of the 1,2-
diadducts detected in the white blood cells of cisplatin-treated patients and the patients’ response to the
treatment, as observed by Reed et al. [6]. However, a causal relationship between the 1,2-intrastrand
crosslinks and anticancer activity in humans has never been demonstrated.
We have previously hypothesized that the cytotoxic effect of cisplatin could be related to the
platinum-DNA monoadducts [7,8]. Our hypothesis was based on the reasoning that the monoadducs, bearing
a labile ligand, could "lure" repair proteins and fix them in a covalent DNA-Pt-protein complex. Such a
ternary complex formation with the recognition part of the UvrABC excinuclease DNA repair system of E.
Coli was indeed observed in an experiment by Lambert et al. [9]. Another indication that the monoadducts
could be related to antitumor activity was the finding that asymmetrical cis-diaminedichloro complexes with
bulky substituents, forming with DNA long-lived monoadducts, showed enhanced cytotoxicity [7,9].
Recently, Natile’s and Farrell’s groups reported substantial in vitro cytotoxicity and in vivo antitumor
activity of trans-[PtCl2L2] complexes, with L being E-imino-ether [10,11] or quinoline [12,13]; these
complexes are characterized by relatively long-lived monoadducs with DNA [14-16].
There is conclusive evidence showing that cis-[PtC12(NH3)2] does not react with DNA directly but
through a solvent-assisted pathway [17-19]. Less clear is whether the monoaquated cisplatin form, cis-
[PtCI(NH3)2(H20)] + (1), or the diaqua complex, cis-[Pt(NH3)2(H20)2]2+ (2), is the major species
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bearing an aqua ligand, can rearrange to diadducts (chelates) directly, the chloro-monoadducts resulting from a
reaction between DNA and 1 have to be hydrolyzed to aqua-monoadducts before further ligand substitution by
a nucleobase 19-21]. Thus, the chloro-monoadducts have considerably longer lifetimes than the aqua-
monoadducts [19,22-25]. The rate of hydrolysis of the former has been shown to depend on the adjacent
bases, in particular on the base 5’ to the platinated guanine [26]. We have recently suggested that this
sequence-dependence could be due to a catalytic action of the phosphodiester group flanking the monoadduct
from the 5’ side. Either a nucleophilic catalysis [27] or a general base catalysis are conceivable mechanisms;
in both cases, the exact positioning of the phosphodiester group, which depends on the nature of the adjacent
bases, would be expected to determine the hydrolysis rate.
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In order to test the possible involvement of the 5’-phosphodiester group in the hydrolysis
mechanism, we have studied in this work the reversible chloride anation of the mononucleotide complex cis-
[Pt(NH3)2(H20)(Me-5’-dGMP)]
/ (3) [equation (1)]. The complexes 3 and 4 are models for respectively aqua-
and chloro-monoadducts formed between cisplatin and DNA. The hydrolysis and chloride anation rate
constants, kH20 and kc1 were compared to those determined in a parallel study of the analogous reaction (2),
1_
cis-[Pt(NH3)2(H20)(Me-5’-dGMP)]
/ +CI cis-[PtCI(NH3)2(Me-5’-dGMP)] + H20 (1)
3 kH20 4
kc1 cis-[Pt(NH3)2(H20)(dGuo)]2+ + CI
knzo
5
cis-[PtCl(NH3)2(dGuo)]+ + H20 (2)
where the nucleotide Me-5’-dGMP was replaced by the nucleoside deoxyguanosine. We were thus able to
quantify the influence of the phosphodiester group on kH20 and kcl.
In addition, we have followed the formation of 3 from 2 and Me-5’-dGMP, and that of 5 from 2
and deoxyguanosine, and determined the appropriate rate constants. The reaction between Me-5’-dGMP and 2
and the reversible anation of 3 (Eq.1) were followed using 1H NMR, whereas the analogous reactions with
dGuo were analyzed by means of reverse-phase HPLC. In the NMR-monitored runs, pH changes during the
reactions were accounted for mathematically, while in the reactions followed by HPLC, the pH was kept
constant. Advantages and disadvantages of both methods are discussed.
2. Experimental
cis-[Pt(ND3)2(D20)2]2+ (2) was prepared by dissolving cis-[Pt(NO3)2(NH3)2] [28,29] in D20. 2’-
deoxyguanosine (dGuo) was purchased from Sigma.
2’-deoxyguanosine-5’-monophosphate-methylester (Me-5’-dGMP) was prepared as ammonium salt
by an adaptation of the method of Miller et al. [30]. 760 mg Dicyclohexylcarbodiimide (DCC, Aldrich) were
added to a suspension of 5’-dGMP (free acid, Sigma, 250 mg) in 100 mL of methanol (Carlo Erba, pro
analysis) and the mixture was stirred 48 h at room temperature. The solvent was evaporated under vacuum to
~3 mL. DCC and its by-products were precipitated by addition of 50 mL of water and filtered off in two
steps: first, using filter paper, and second, passing through a D4 glass frit (filtering over frit directly congests
the frit). The filtrate was extracted with 3x20 mL of cyclohexane, evaporated under vacuum to ~10 mL and
the rest lyophilised to dryness. The colorless microcrystalline material obtained was dissolved in ~3 mL D20
and the solution passed through a column filled with ~0.5 mL of a Dowex(R)-50 resin (Sigma) charged with
NH4+ and rinsed with D20. The purity of the collected fractions was checked using 1H NMR. The fractions
with satisfactory purity were assembled and lyophilized. The final product was stored under argon at -32 C.
A thermoanalysis revealed a 5.73% weight loss in the temperature range between 30 and 120 C, with a
maximum rate at 70 C, and a 15.13% weight loss between 120 and 250 C, with a maximum rate at 170
C. The first step was completely reversible when the sample was kept under ambient atmosphere, and was
attributed to 1.5 equivs, of "adsorbed" H20 (theor.: 6.54%). During the second, irreversible step, the sample
turned black, indicating decomposition. Anal. (deuterated sample): Calcd. for C HI DsN607P 1.5 D20: C,
31.74; N, 20.19%. Found: C 31.10; N, 19.48%.Tiphaine Weber et al. Metal-Based Drugs
The samples for the kinetic runs to be followed by NMR were prepared by weighing all quantities
(including the liquid components) using a semimicro balance (precision +_0.01 mg). All reactions were
carried out in 0.1 M NaC104 at 20 C. The H NMR spectra were recorded on a Bruker ARX 250
spectrometer with 3-trimethylsilyl(2,2,4,4-D4)propionate as reference. The HDO peak was suppressed by
means of presaturation.
The reaction between 2 and deoxyguanosine was followed using the HPLC-based method described
by Gonnet et al. [31 ]. The samples withdrawn at different time intervals were quenched by addition of KC1 in
excess and by cooling down to liquid nitrogen temperature. The pH was kept within 4.5+_0.1 by addition of
HC104. The HPLC analysis was performed using a Beckman 126 pump coupled to a Beckman diode array
detector 168 and a System Gold V810 integrator. The system was connected to a Rheodyn 7125 valve. A
cation exchange HPLC column Nucleosil SA, 250 x 4.6 mm, ID 5 mm (Colochrom, France) was
employed, the mobile phase was sodium NaC104 0.25 M (pH 4.4 adjusted by HC104) for 15 minutes and a
gradient to 0.5 M for 30 minutes, flow rate mL/min; column temperature 50C. The detection wavelength
of 258 nm was that of the quasi-isosbestic point of the overall reaction. The elttion times increased with
increasing positive charge of the eluted species, i.e., deoxyguanosine < cis-[PtCl(NH3)z(dGuo)]+ (6) < cis-
[Pt(NH3)z(dGuo)2]2+.
For the kinetic .nalysis of the reversible hydrolysis of 6, the same reaction was carried out with 2
in twofold excess over deoxyguanosine, so that the yield of ti was maximized. After one hour reaction time
at room temperature, the same volume of saturated NaC1 solution was added to the reaction mixture in order
to replace all aqua ligands with chloride. The mixture was subjected to cation exchange HPLC separation
using the same conditions as described above, and 6 collected at the outlet was immediately cooled to liquid
nitrogen temperature. This solution, which was 0.5 M in NaC104, was subsequently used to follow the
establishment of the hydrolysis equilibrium (Eq. 2). The reaction was started by diluting 5 times with water,
warming up to 20 C and adjusting the pH to 4.5+0.1 by addition of HC104. The pH was kept within this
range by eventual addition of NaOH. The total content in deoxyguanosine was quantified
spectrophotometrically by measuring the absorbance at the .quasi-isosbestic point (258 nm), with the molar
absorption coefficient e258 determined as 12300 M’lcm1 from a deoxyguanosine solution of a known
concentration. The kinetics of the reversible hydrolysis of 6 to 5 was followed by withdrawing aliquots and
analyzing them immediately using the same cation exchange HPLC system. Six independent experiments
were carried out. An exactly determined quantity of NaC1 (~1 equiv, with respect to 6) was added to the
solution of 6 at the beginning of two experiments.
3. Results
3.1. Kinetics of the reaction between 2 and Me-5’-dGMP
The reaction scheme is depicted in Scheme 1. The guanine H8 resonances of the species 3
(8.30<5H8<8.57; see Figure 1) and 7 (5H8 8.42 ppm) are downfield from that due to the free ligand (5H8
8.08 ppm); integration of the H8 peaks could therefore be used for concentration measurements. The
chemical shift of H8(3), which is sensitive to the deprotonation of the aqua ligand (PKa3 7.03+_0.06 in
D20 as well as to that of the guanine N1 atom (PKa(N1) 9.16+_0.06 in D20), has been utilized as an
internal pD indicator (Figure 1)s. We have followed the reactions between 2 and Meo5’-dGMP (L) in two
different runs: i) in acidic milieu, where the reaction along kLl was preponderant, and ii) in neutral medium,
where a major fraction of 2 was deprotonated to 2-D and thus the pathway involving kL2 was more
important.
The establishment of the protolytic equilibria is, of course, rapid, therefore, the integration ofNMR
peaks allows only the sum [3tot] [3] + [3-D] to be determined. The differential equations for the time-
derivatives of ILl, [3tot], and [7] are shown below along with that for [2tot], defined as [2tot] [2] + [2-D]
+ [2-2D]
d[L]/dt =-(kLl[2] + kLz[2-D] + kBIS[3])[L] (3a)
d[2tot]/dt =-(kLl[2 + kLZ[2.D])[L (3b)
d[3tot]/dt (kLl[2] + kLz[2-D] kBIS[3])[L] (3c)
d[7]/dt kBis[3][L] (3d)
Numerical integration of these differential equations yields the theoretical concentration curves.
Obviously, the calculation of the time-derivatives (Eq. 3a-d) requires the concentrations of the
specific protolytic forms, [2], [2-D], and [3], to be defined. This can be achieved using two different
approaches, one applicable in the acidic solution, and the other in the neutral milieu, as explained in the
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Conversion of these pKa values obtained in D20 solution to H20 according to Martin [32] yields PKa3
kL2
L D20
pKal 5.90a
PKa2 7.77a
PKa3 =7.03b
2-2D
Scheme 1. Reaction between cis-[Pt(ND3)2(D20)2]2+ (2) and Me-5’-dGMP (L) in D20. a extrapolated for D20 from [32] and [33].
b determined from the titration curve in Figure 1.
5(H8) [ppm]
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Figure 1. The H8 chemical shift of cis-[Pt(ND3)2(D20)(Me-5’-dGMP)]+ (3) in
D20 as a function of pD. The full line rep.resents a double-sigmoidal function
5(H8) [ppm] p + q[10(s’pD)/(1 + 10(s’pD))] + r[10(t’pD)/(1 + 10(t’pD))], with
p 8.301 ppm, q 0.152 ppm, r 0.110 ppm, s 9.158, 7.028. p, p+q,
and p+q+r represent the H8 chemical shifts of the unprotonated,
monoprotonated, and doubly protonated forms of 3, respectively; s and are the
pKa values corresponding to the (de)protonation of the guanine N1 and of the
aqua ligand, respectively.
3.1.1. Reaction in acidic medium
When approximately stoichiometric, exactly determined quantities of 2 and L were mixed in an
NMR tube so that the initial concentrations were --4 mM, the pD of the reaction mixture remained withinTiphaine Weber et al. Metal-Based Drugs
the limits 5.3<pD<5.6 in the course of the reaction. In these conditions, the protolytic equilibrium Ka2
(Scheme 1) could be neglected, and dissociation of 2 (Kal) and of 3 (Ka3) could be considered as the only
sources of D+. The reduced system of equations characterized by the rate constants kLl, kL2, kBiS, and the
equilibrium constants Kal and Ka3 leads to a cubic equation for [2-D]:
a[2-D] 3 + b[2-D]2 +c[2-D] + d 0 (4)
with a Ka3 Kal
b Ka3[3tot] + Kal(Ka3 + [2tot] Kal)
c Ka [2tot] (2Kal Ka3)
d Kal2[2tot]2
and [2tot] [2] + [2-D] [3tot] [3] + [3-D] [2-2D] 0
From the three theoretical roots of Eq.(4) [34], the physically meaningful one was found to be that shown in
Eq.(5):
[2-D] =-2Ql/2cos[(0+4r)/3] b/3a (5)
with Q [(b/a)2 -3c/a]/9
0 arccos(R/Q3/2)
R [2(b/a)3 9bc/a2 + 27d/a]/54
From the balance for [D+], we have
[D+] Kal([2tot]- [2-D])/[2-D]
[2] [2-D][D+]/Ka
[3-D] [D+]-[2-D]
[3] [3tot] [3-D]
For any given set of instantaneous concentrations [L], [2tot], [3tot], and [7], we can thus express their time-
derivatives (Eq. 3a-d) by means of the rate constants kLl, kL2, kBiS, the equilibrium constants Kal and Ka3,
and the concentrations [L], [2tot], [3tot], and [7] themselves.
3.1.2. Reaction in neutral milieu
In a second experiment, approximately stoichiometric, exactly determined quantities of 2 and L were
mixed in an NMR tube with an equimolar amount of NaOD, so that the initial concentrations were -.8 mM.
The initial pD was 6.7 and increased to 7.7 in the course of the reaction. In this case, neither equilibrium of
Scheme could be neglected, and a purely analytical determination of [D/], [2], [2-D], and [3] became
impossible. We then took advantage of the fact that the pD range lie in the buffer zone of 3 (pKa3 7.03 in
D20), and could thus be monitored using the chemical shift of H8(3) (Figure 1) with precision. A fit
function of the form
[D+] p + q exp(-r 1/2) (6)
(t is the time in seconds), with the coefficients (optimized using the program Kaleidagraph) p 2.2968x 10-8
M, q 1.7583 M, and r 0.014189 s/2, was found to describe very well the experimental [D+]-time curve
(Figure 2). The fit function (6) enabled us to convert the experimental [D+]-time curve into an analytical
expression for [D+], from which the remaining concentrations required for the differential equations (3a-d)
could easily be determined:
[2-D] [2tot]/([D+]/Kal + Kaz/[D+] + 1)
[2] [2-D][D+]/Ka
[3] [D+][3tot]/(Ka3 + [D+])
3.1.3. Evaluation of the platination rate constants
While in acidic medium, L reacts almost exclusively with the diaqua form 2 (pathway along kLl),
in neutral medium, 2 converts preponderantly to the aqua-hydroxo form 2-D, and the reactions of the latter
(along kL2 become important. In order to obtain precise and consistent values for kLl, kL2, and kBlS, the
experimental curves for [L] and [3tot] were fitted simultaneously for both reactions (Figure 3). (Since [7] is
related to [L] and [3tot] via the constant sum of all the H8 peak integrals, fitting its curve would be
redundant.) The optimized rate constants are given in Table together with those determined for the
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Figure 2. Concentration of D+ measured for the reaction run between Me-
5’-dGMP- and 2 in neutral solution, as a function of time (.). The H8
chemical shift of 3 was used as pD indicator (see Figure 1). The solid line
represents the fit function [D/]- p + q exp(-r tl/2), with the optimized
coefficients p 2.2968x10-8 M, q 1.7583 M, and r 0.014189 sq/2.
3.2. Kinetics of the reversible chloride anation of 3
In this part of the work, we have followed the establishment of the equilibrium between 3 and 4
(Eq. 1) in 0.1 M NaC104 at 20 C from approx, stoichiometric amounts of 3 and NaC1. For this purpose, 2
was first allowed to react with equiv, of Me-5’-dGMP (Section 3.1.1). At the end of the reaction, the exact
Concentration
x O. 1 [mM]
14
11
o 2 . 6 8 10 12 14. 16 18 :20
Tme 10 [s]
Figure 3. Experimental (+) and calculated (full line) concentration curves
for Me-5’-dGMP- (L) (descending curves) and 3tot (ascending curves), for the
reactions between L and 2 in acidic (faster reaction, terminated after ca.
2x 104s, shown enlarged in the inset) and neutral (slower reaction, followed
until ca. 17x104s) aqueous 0.1 M NaC104 at 20 C. The rate constants kLl,
kL2, and kBls were iterated in order to fit simultaneously all four curves.
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Table 1. Rate constants for the platination of cis-[Pt(NH3)2(H20)2]2+ (2) with deoxyguanosine and Me-5’-
dGMP. Standard deviations are given in parentheses.
kL1 [Mlsll 0.117(1) 1.18(3) [
[kL2 [Mlsl] n.d. 0.016(3) ]
[,,,ku,s [M-Is’l,] 0.9’73(? 0.129(3) ]
n.d., not determined
concentrations of 3, 7, and of the remaining starting complex 2 were evaluated, and a precisely determined
amount of NaC1 (approx. equiv, with respect to 3) in a small volume of D20 was injected to the NMR
tube. The guanine H8 signals of 3 and 4 were again used for concentration measurements. The H8 chemical
shift of 3 was constant (8.576+0.004 ppm) during this experiment, indicating that the pD of the reaction
mixture remained inferior to 5. The H8 chemical shift of 4 (8.45 ppm) was well separated from that of 3,
but overlapped with that of 7 (8.42 ppm). However, since the concentration of 7 did not change during the
chloride anation of 3, the integral under the peak of 7 could be evaluated at the beginning of the reaction and
then subtracted from the sum 4+7.
The kinetic study of the reversible chloride anation of 3 in situ was complicated by the presence of
the unreacted diaqua complex 2 remaining in the tube. This complex can undergo chloride anation to cis-
[PtCI(ND3)2(D20)]+ and, in a second step, to cis-[PtClz(ND)2], and acts therefore as scavenger of C1-. It
was therefore necessary to take the two-step anation of 2 (Eq.7) explicitly into account.
2+ kl k2
ND3 -’-] Cl" D20 ND3---]+ Cl," D20 ND3
D3N’-Pt- OD2 lt OD2 D3N-- D3N--Pt-- Cl
OD2 CI D20 CI CI D20 CI
k -1 k -2
(7)
2 8 9
Since the mixture remained acidic (pD < 5) during the reaction, the deprotonation of 2-D (Ka2)
and of 3 (Ka3) (Scheme 1) as well as that of 8 (pKa 6.96; extrapolated for D20 from [33]) could be
neglected. The only protolytic equilibrium that has been taken into account was thus that between 2 and 2-
D (Kal, Scheme 1).
The differential equations to be integrated are thus according to the equations (1) and (7):
d[3]/dt =-kcl[3][C1- + kH20[4]
d[C1-]/dt =-kcl[3][C1- + kH20[4 -kl[2][Cl- + k_l[8 k218][Cl- + k_219
d[2tot]/dt -kl [2][C1-] + k_! [8]
d[8]/dt kl[2][C1-] k_l[8] k218][C1- + k.219
with [9] [2tot]O [2tot] [8]
[4] [3]o- [3]
[2-D] =0.5 Kal[(1 + 4[2totl/Kal) 1/2- 1]
[2] [2tot]- [2-D]
where the index 0 indicates the appropriate value at time 0.
(Sa)
(8b)
(8c)
(8d)
Simultaneous fit of the theoretical curves for [3] to the experimental concentrations from two
experiments (fitting of the curve for [4] would be redundant, since [3] + [4] const.) are shown in Figure 4.
The optimized rate constants (Eq. 1) are listed in Table 2 together with those for the reaction (2).
3.3. Kinetics of the reaction between 2 and deoxyguanosine
The reaction between 2 and deoxyguanosine was followed in aqueous 0.1 M NaCIO4 at constant pH
(4.5_+0.1). At this pH, the acid-base equilibria Kal, Ka2 and Ka3 of Scheme (substitute dGuo for L in
Scheme 1; beware that the pKa values are given for D20 can be neglected, and we are left with the two
consecutive reactions along kL and kgls. The concentration curves for dGuo, cis-[Pt(NH3)2(dGuo)(H20)]2+
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(5), and cis-[Pt(NH3)2(dGuo)2]2+, determined by reverse-phase HPLC, are shown in Figure 5, and the
optimized rate constants are given in Table 1.
Concentration [M]
(3.034
O.1302
0.001
0 2,5 50 75 ’100 12,5
Time xl0 Is]
Figure 4. Experimental (+) and calculated (full line) concentration curves
for [3] for two runs in which approx, stoichiometric amounts of 3 and NaC1
were mixed in 0.1 M NaC104 at 20 C. The rate constants kcl and kH20
were iterated in order to fit simultaneously both experimental curves.
Table 2. Hydrolysis and chloride anation rate constants for the reversible reactions
kc1 -1(+) cis-[Pt(NH3)z(H20)L](2)+ + CI" cis-[PtCI(NH3)zj + H20 (L dGuo; Me-5’-dGMPI
kH20
Standard deviations are given in parentheses.
L dGuo Me-5’-dGMP-
kH20 [s-l 1.3( 1)x 10-5 0.9(1 )x 10.5
kcl [M-Is1] 7.5(4)x10-2 1.0/1)xl0-2
3.4. Kinetics of the reversible hydrolysis of cis-[PtCl(NH3)2(dGuo)]+ (6)
The monochloro-monodeoxyguanosine complex 6 was isolated from a chloride-rich solution of 5
(see Section 2) using cation-exchange HPLC, and the establishment of the equilibrium (2) in 0.1 M NaC104
at pH 4.5_+0.1 was followed using analytical cation-exchange HPLC runs. The deprotonation of the aqua
ligand of 5 to cis-[Pt(OH)(NH3)z(dGuo)] + (5-H) could be quantified using the pKa value determined
previously (5.43_+0.15 in D20 [35]; 4.91-+0.15 in H20 [32]):
[5] [5tot] [H+]/(Ka + [H+]) (9)
with [Stot] [5] + [5-HI
Eq. (9) yields, with [H+] 10-4.5 and Ka- 10-4"91, 72 % of 5 and 28 % of 5-D. These percentages have
been taken into account in the simulation of the concentration curves for 5to and 6 (Figure 6). It was
assumed that the hydroxo form 5-H is inert towards substitution. Optimization of the rate constants yielded,
after optimization, the values listed in Table 2.
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Concentration [M]
O.C’O1
/
O,OCO ,.....,,.._..a- ,-’-"-
o 20OO 4OO0 ooo
Time Is]
Figure 5. Experimental (+) and calculated (full line) concentration curves
]2+ for deoxyguanosine (descending curve), cis-[Pt(NH3)2(dGuo)(H20)]2/ (ascending curve, major final product), and cis-[Pt(NH3)2(dGuo)2
(ascending curve, minor final product), from a reaction between
deoxyguanosine and 2 equivs, of 2 in 0.1 M NaCIO4 at 20 C.
Concentration
x 10-6 [M]
Time x 10
4 Is]
,,I
2 4 6
Figure 6. Typical experimental (-) and calculated (full line) concentration
curves for 6 left to equilibrate in 0.1 M NaC104 at 20 C.
4. Discussion
4.1. Effect of the attachment of a 5’-methylphosphoester group on the reactivity of deoxyguanosine and its
platinum complexes
In the first part of this work (sections 3.1 and 3.3), we evaluated the rate constants for the two
consecutive reactions of Me-5’-dGMP- with cis-[Pt(NH3)2(H20)2]2+ (2), and for the analogous reactions of
deoxyguanosine. The rate constants (Table 1) show that the substitution of the first aqua ligand of 2 (kL1;
see Scheme 1) is accelerated by a factor of 10 by the phosphodiester group. The substitution of the second
aqua ligand of 2 (kBls) is accelerated only by a factor of ~2. Two effects are probably responsible for the
observed acceleration of the reactions with Me-5’-dGMP-: i) the negative charge of Me-5’-dGMP-, which is
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expected to favor strongly the interaction with the dicationic species cis-[Pt(NH3)2(H20)2]2+ and somewhat
less efficiently that with the monocationic complex cis-[Pt(NHa)E(HEO)(Me-5’-dGMP)]+; ii) hydrogen
bonding between the aqua and ammine ligands of platinum and the 5’-phosphodiester group [36]. Since both
effects are expected to be stronger for the first reaction (kLl), the smaller rate enhancement observed for kaIs,
as compared to kLl, does not allow to conclude which effect is more important.
For the reaction system involving Me-5’-dGMP’, we have also determined the rate constant kL2
characterizing the reaction with the deprotonated form of 2, cis-[Pt(OD)(NDa)E(D20)]+ (2-D) (Scheme 1;
Table 1). The ratio kLl/kL2 of ~100 indicates that the affinity of 2 for Me-5’-dGMP" is decreased by two
orders of magnitude upon deprotonation of 2. For comparison, the reaction between 2 and the nucleoside 1-
methylinosine is slowed down only by a factor of 10 upon deprotonation [37]. This difference can be
plausibly attributed to the negative charge of Me-5’-dGMP’, which should "feel" the decrease of positive
charge from 2 to 2-D, whereas there is no net charge-charge interaction between the platinum complexes and
1-methylinosine. Interpolating between Me-5’-dGMP" (charge -1) and 1-methylinosine (charge 0) to
double-stranded DNA, where the average nucleotide charge is approx. -0.25 e [38,39] we would expect that
deprotonation of 2 should reduce the reactivity towards DNA nucleobases by a factor between l0 and 100. In
contrast to this prediction (as well as to chemical intuition) is the observation reported by Johnson et al.
that deprotonation of cis-[Pt(NH3)E(H20)2]2+ does not alter its reactivity towards calf thymus DNA [40]. A
detailed re-examination of the reactivities of 2 and 2-D towards duplex DNA would be needed to clarify this
point.
In the second part (sections 3.2 and 3.4), we investigated the establishment of the hydrolysis-anation
equilibrium for the reactions (1) and (2), respectively. The rate constants shown in Table 2 indicate that
whereas the chloride anation of cis-[Pt(NHa)E(HEO)(Me-5’-dGMP)]+ (3) in 0.1 M NaC104 is ~7 times slower
than that of cis-[Pt(NH3)E(HEO)(dGuo)]2/ (5), the reverse hydrolysis reactions proceed with very similar
rates. This result seems to invalidate the hypothesis of Kozelka and Barre, according to which the 5’-
phosphodiester group adjacent to a guanine coordinating a cis-PtCl(NH3)2
/ residue would act as a
nucleophilic catalyst and accelerate in a sequence-dependent manner the hydrolysis of the monoadduct [27].
4.2. Methodological considerations
In this work, two very similar reaction systems were analyzed using two quite different approaches.
The system involving deoxyguanosine was investigated classically [31,37] in a reaction vessel from which
samples were withdrawn and analyzed by means of HPLC. This setting allows the pH to be measured and
adjusted continuously, which considerably simplifies the data analysis. Such a practice becomes problematic,
however, when the experiments have to be carried out in neutral solution, where pH adjustments are
extremely delicate.
NMR offers the opportunity of performing in situ qualitative and quantitative analysis of the
products consumed and formed during a reaction. However, no pH adjustments during the reaction are
possilgle with current spectrometers. Workers using NMR for kinetic measurements therefore usually either
choose acidic or alkaline reaction conditions involving only small pH changes, or recur to buffers. Buffer
systems, however, inevitably include potential ligands, and data recorded for reactions involving metal
complexes in buffered solutions are therefore frequently ambiguous. Specifically, the phosphate buffer,
typically used to maintain neutral or quasi-neutral pH, has been shown to compete effectively with other
nucleophiles for platinum(II) binding [41 ]. We have therefore followed, in the part involving Me-5’-dGMP’,
an alternative approach, in which the pH is not regulated, but left to evolve, and the pH changes are taken
explicitly into account in the kinetic simulation. Two options of this demarche are presented: the theoretical
approach, where the concentration ofH+ (actually: D+) is calculated from the known dissociation constants,
and the experimental approach, employing an internal pD indicator. The application of the theoretical
approach was particularly straightforward for the reaction between Me-5’-dGMP" and 2 in acidic solution
(Section 3.1.1.), where only two acid-base equilibria were to be taken into account, and the proton
concentration could thus be derived analytically. The same reaction in neutral medium, on the other hand,
involved three protolytic equilibria (Scheme 1), and the calculation of [D/] would have had to be carried out
numerically. The introduction of an iterative subroutine within each cycle of the routine integrating the
differential equations would have considerably slowed down the integration-optimization procedure and would
have possibly jeopardized the convergence. Therefore, we recurred to the experimental approach. The
experitnental [D+]-time curve was introduced into the integration routine by means of a fit function (Figure
2).
In summary, replacing pH control by mathematical accounting for pH changes in the evaluation of
the rate constants has allowed us to study in a convenient way a relatively complicated system of reactions.
14Tiphaine Weber et al. Metal-Based Drugs
This approach requires only a moderately increased computational effort, which should be manageable by any
chemist familiar with basic algebra.
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